|
Market Closed -
Boerse Muenchen
16:43:36 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 26.50 EUR | 0.00% |
|
-3.64% | -11.07% |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-05 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
| Market Cap | 458M 530M 431M 392M 736M 50.61B 748M 5.05B 1.97B 25.38B 1.99B 1.95B 84.51B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 411M 475M 386M 351M 659M 45.32B 670M 4.52B 1.77B 22.73B 1.78B 1.74B 75.68B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
| 1 week | -3.64% | ||
| Current month | -2.21% | ||
| 1 month | -2.21% | ||
| 3 months | -7.67% | ||
| 6 months | -10.02% | ||
| Current year | -11.07% |
| 1 week | 26.5 | 27.5 | |
| 1 month | 26.5 | 27.5 | |
| 3 years | 20.5 | 55.9 | |
| 5 years | 20.5 | 55.9 | |
| 10 years | 20.5 | 91.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 2024-12-31 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 2011-06-30 |
| Director/Board Member | 54 | 2010-03-09 | |
| Director/Board Member | 51 | 2013-05-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -3.64% | +22.12% | -48.44% | 531M | ||
| -0.85% | -1.30% | -10.66% | -8.03% | 13.35B | ||
| -1.45% | -1.41% | -32.69% | -56.83% | 5.05B | ||
| -1.44% | -3.58% | +2.63% | +0.58% | 4.98B | ||
| -0.82% | +4.31% | +5.02% | -30.41% | 4.24B | ||
| -1.69% | -1.90% | -15.41% | -7.38% | 3.65B | ||
| -1.96% | -9.52% | -8.48% | -2.27% | 3.42B | ||
| -0.65% | -1.03% | -5.95% | +15.00% | 3.42B | ||
| -0.56% | +3.11% | -14.19% | -15.51% | 2.5B | ||
| +2.56% | +13.21% | +2.78% | -9.09% | 1.76B | ||
| Average | -0.76% | -0.85% | -5.48% | -16.24% | 4.71B | |
| Weighted average by Cap. | -0.97% | -1.82% | -9.27% | -13.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 564M 459M 417M 782M 53.83B 796M 5.37B 2.1B 27B 2.12B 2.07B 89.89B | 501M 580M 471M 428M 804M 55.32B 818M 5.52B 2.16B 27.75B 2.18B 2.13B 92.39B |
| Net income | 11.34M 13.11M 10.66M 9.69M 18.19M 1.25B 18.51M 125M 48.83M 628M 49.22M 48.15M 2.09B | 32.64M 37.75M 30.7M 27.9M 52.39M 3.6B 53.3M 360M 141M 1.81B 142M 139M 6.02B |
| Net Debt | -49.74M -57.52M -46.78M -42.51M -79.82M -5.49B -81.21M -548M -214M -2.75B -216M -211M -9.17B | -47.86M -55.34M -45.01M -40.91M -76.8M -5.28B -78.14M -527M -206M -2.65B -208M -203M -8.82B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change |
|---|---|---|
| 26-08-14 | €26.50 | 0.00% |
| 26-08-13 | €26.50 | 0.00% |
| 26-08-12 | €26.50 | 0.00% |
| 26-08-11 | €26.50 | -0.75% |
| 26-08-10 | €26.70 | -2.91% |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
- BON Stock
Select your edition
All financial news and data tailored to specific country editions
















